Scientists at Newcastle University, working with biotechnology companies OJ-Bio Ltd and Orla Protein Technologies, are developing a novel device which has great potential in rapidly detecting the early signs of gum disease and monitoring improvement as the condition is treated. The government-backed Technology Strategy Board and the Engineering and Physical Sciences Research Council (EPSRC) have awarded the grant funding to the £1.3m project to help the consortium develop the prototype into a commercial product.
The project will deliver a device that will enable patients and dentists to monitor gum disease accurately, simply and cost effectively, by identifying signs of the disease in saliva.
Gum or periodontal disease is a major healthcare problem in the western world and has been linked with an increased risk of diabetes and other medical problems.
The funding allows OJ-Bio and Orla to work with leading scientists Dr John Taylor and Professor Philip Preshaw, from the Institute of Cellular Medicine (ICM) & Centre for Oral Health Research (COHR) at Newcastle University.
Principal investigator Dr Taylor (pictured) said: “We are delighted to obtain the funding for this project which is an exciting combination of laboratory and clinical investigations building on our existing strengths in biomarker research. This is an excellent example of translational biomedical research which will not only deliver new technology for patient benefit, but will also generate important information about the molecular biological processes which underpin chronic inflammatory diseases.”
Click here to read the full press release.
published on: 13th June 2012